AHS Cancer Control Alberta

πŸ‡¨πŸ‡¦Canada
Ownership
Private
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy

Completed
Conditions
Prostate Cancer
First Posted Date
2005-08-05
Last Posted Date
2016-02-24
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
1000
Registration Number
NCT00126815
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment

Terminated
Conditions
Colon Cancer
First Posted Date
2005-08-05
Last Posted Date
2019-07-05
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
29
Registration Number
NCT00126867
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer

Phase 1
Conditions
Prostate Cancer
First Posted Date
2005-08-05
Last Posted Date
2016-07-06
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
60
Registration Number
NCT00126802
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation

Not Applicable
Completed
Conditions
Prostatic Neoplasm
First Posted Date
2005-08-05
Last Posted Date
2016-02-25
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
10
Registration Number
NCT00126854
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer

Phase 1
Completed
Conditions
Carcinoma, Small Cell
First Posted Date
2005-08-05
Last Posted Date
2016-02-24
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
18
Registration Number
NCT00126828
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

Comparative 2-D Tumor Analysis in Familial Gliomas

Completed
Conditions
Malignant Glioma
First Posted Date
2005-08-02
Last Posted Date
2016-07-18
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
5
Registration Number
NCT00125710
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy

Completed
Conditions
Malignant Glioma
First Posted Date
2005-08-02
Last Posted Date
2016-07-18
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
49
Registration Number
NCT00125697
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

Sublingual Methadone for the Management of Cancer Breakthrough Pain

Phase 1
Completed
Conditions
Cancer
Pain
First Posted Date
2005-08-01
Last Posted Date
2017-09-25
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
10
Registration Number
NCT00125294

Megavoltage CT (MVCT) Imaging for Intracavitary Radiation Treatment in Cervix Cancer

Completed
Conditions
Cervix Cancer
First Posted Date
2005-07-28
Last Posted Date
2016-02-26
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
5
Registration Number
NCT00124423
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation

Completed
Conditions
Prostate Cancer
Osteoporosis
First Posted Date
2005-07-28
Last Posted Date
2016-02-25
Lead Sponsor
AHS Cancer Control Alberta
Target Recruit Count
100
Registration Number
NCT00124410
Locations
πŸ‡¨πŸ‡¦

Cross Cancer Institute, Edmonton, Alberta, Canada

Β© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy